Targeting cancer through enhanced tumor visualization
Member count: 11-50
Total raised: $30.2M
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Colle Capi... | colle.vc |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 19.10.2022 | Series B | $21.5M | - | finsmes.co... |
| 12.06.2018 | Series A | $8.7M | - | finsmes.co... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 19.10.2022 | Vergent Bi... | - | - | - | colle.vc/n... |
| 04.10.2022 | Vergent Bi... | - | Stories F... | - | bizjournal... |
| 04.10.2022 | Vergent Bi... | Vergent Bioscience, a Minneapo... | USA | - | finsmes.co... |
| 10.04.2022 | Vergent Bi... | - | - | - | springmoun... |
| 12.06.2018 | Vergent Bi... | MINNEAPOLIS, MN, Vergent Bio... | - | - | vcnewsdail... |
| 12.06.2018 | Vergent Bi... | Vergent Bioscience, a Minneapo... | USA | - | finsmes.co... |
| - | Vergent Bi... | “Vergent Bioscience’s lead com... | - | - | fastfounde... |
| - | Vergent Bi... | “Targeting cancer through enha... | - | - | fastfounde... |